- Active not recruitingPHASE2
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma
This study is looking at a new medicine called rocatinlimab for people aged 18-75 with moderate to severe asthma. It wants to see if the medicine can reduce asthma attacks. Participants will receive either rocatinlimab or a dummy medicine called a placebo.
For: AsthmaUnited States · Argentina · Australia - Active not recruitingPHASE3
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis
This study is testing a new medicine, rocatinlimab, for adults with prurigo nodularis. It's designed to see if the medicine can reduce itching and improve skin compared to a dummy medicine, to help people with this itchy skin condition.
For: Prurigo NodularisUnited States · Argentina · Australia - Active not recruitingPHASE3
A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
This study looks at the long-term effects of a new medicine, rocatinlimab, for teenagers and adults with moderate to severe eczema. It checks how safe and well-tolerated the medicine is, and if it continues to help over time.
For: Atopic DermatitisUnited States · Argentina · Australia